Cargando…
Risk of heparinoid use in cosmetics and moisturizers in individuals vaccinated against severe acute respiratory syndrome coronavirus 2
Recently, heparin-induced thrombocytopenia (HIT) after vaccination with the vaccines manufactured by AstraZeneca and Pfizer–BioNTech has been published in the New England Journal of Medicine. These reports state that heparin was not used around the vaccination period in all cases. HIT after vaccinat...
Autor principal: | Yamamoto, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443895/ https://www.ncbi.nlm.nih.gov/pubmed/34530838 http://dx.doi.org/10.1186/s12959-021-00320-8 |
Ejemplares similares
-
Comment on evidence for and against vertical transmission of severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019)
por: Brion, Luc Pierre, et al.
Publicado: (2020) -
Immune response to the severe acute respiratory syndrome coronavirus 2 vaccines: Is it sustained in the diabetes population?
por: Rouka, Erasmia, et al.
Publicado: (2022) -
Asymptomatic Severe Acute Respiratory Syndrome–associated Coronavirus Infection
por: Lee, Harold K.K., et al.
Publicado: (2003) -
The neuroinvasive potential of severe acute respiratory syndrome coronavirus 2
por: Sun, Tong, et al.
Publicado: (2020) -
Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix
por: Di Giacomo, Anna M., et al.
Publicado: (2021)